Laboratorios Farmaceuticos Rovi, S.A.

€68.60As of Sun 8 Nov 2026, 12:00 UTC
BME:ROVIHealthcare
Country Spain
PE (Fwd) •••
TSR 10Y CAGR 20.02%
Div yield 1.40%
ROE 28.71%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.28
PE TTM 17.07
TSR TTM 14.60%
Mkt cap €3.508B
ROIC 17.72%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€76
10.29%
(35.71%)
Hold 9|8|4|12|0
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.70
0.76
0.75
0.81
7.24%
20.37%
20.91%
24.31%
Revenue€M
232.8
226.6
232.3
233.9
4.79%
3.44%
1.21%
4.43%
Peers (US$3.939B)
Cap (US$)
PE
2.744B
40.61x
1.708B
19.00x
3.934B
28.04x
Capital
TTM
5Y
10Y
Leveragex
0.930
(0.037)
(0.023)
EBIT/Intx
0.414
0.265
0.256
Own earn%
(147.86)
(30.78)
(33.28)
Sh yield%
21.50
5.25
4.67
Owners
Insiders/Inst%
9.39
60.97
Short interest%
4.72
SBC / revenue%
3.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
14–20
$1 testx
—
Incr. ROIC%
62